Abstract

APOBEC (Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) enzymes may involve in mutagenic processes in multiple cancer types, including lung cancer. APOBEC family of cytidine deaminases induces base substitutions with a stringent TCW motif, which is widespread in multiple human cancers. We hypothesized that common missense variants in coding regions of APOBEC genes might damage the structure of proteins and modify lung cancer risk. To test this hypothesis, we systematically screened predicted deleterious polymorphisms in the exon regions of 10 APOBEC core genes (APOBEC1, APOBEC2, APOBEC3A, APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, APOBEC3H, and APOBEC4) and evaluated them with a case-control study including 1200 cases and 1253 controls. We found that the T allele of rs139293 in exon 2 of APOBEC3H was significantly associated with decreased risk of lung cancer (odds ratio = 0.76, 95% confidence interval: 0.63–0.91). Similar inverse association of this variant was observed in subgroups. Further study showed that the T allele of rs139293 was associated with the altered expression of APOBEC3H and APOBEC3C and that the two genes were co-expressed in both tumor and adjacent normal tissues. These results indicate that genetic variants in APOBEC3H may contribute to lung cancer susceptibility in Chinese population.

Highlights

  • Lung cancer is the leading cause of cancer-related death, leading to 1.6 million deaths worldwide in 20121

  • The T allele of rs139293 was significantly associated with decreased risk of lung cancer with a per-allele adjusted odds ratio (OR) of 0.76 (95% confidence interval: 0.63–0.91, P = 0 .002)

  • We systematically evaluated the association of common missense genetic variants in exons of core APOBEC genes and lung cancer risk in a case-control study including 1,200 cases and 1,253 healthy controls

Read more

Summary

Introduction

Lung cancer is the leading cause of cancer-related death, leading to 1.6 million deaths worldwide in 20121. Recent genome-wide association studies (GWAS) have identified numerous loci related to lung cancer risk[2,3,4,5,6,7,8,9,10,11]. The study of APOBEC signature mutation based on whole-exome sequence data from The Cancer Genome Atlas (TCGA) suggests that cytosine deamination catalyzed by APOBEC enzymes is a mutagenic mechanism in multiple cancer types, including lung cancer[18,19]. We systematically screened common missense variants with predicted damaging effects in the exon regions of 10 APOBEC core genes (APOBEC1, APOBEC2, APOBEC3A, APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, APOBEC3H, and APOBEC4) and conducted a case-control study including 1,200 cases and 1,253 controls to investigate the associations between these variants and lung cancer risk

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call